pyrazines has been researched along with Glomerulonephritis, IGA in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, Y; Gong, X; Hei, TK; Ye, Z; Zheng, J | 1 |
Alloway, RR; Cardi, MA; Krisl, JC; Shields, AR; Woodle, ES | 1 |
Tang, X | 1 |
1 trial(s) available for pyrazines and Glomerulonephritis, IGA
Article | Year |
---|---|
[Effect of ligustrazine on proliferative glomerulonephritis].
Topics: Adolescent; Adult; Creatinine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Losartan; Male; Middle Aged; Prednisone; Pyrazines; Serum Albumin | 2003 |
2 other study(ies) available for pyrazines and Glomerulonephritis, IGA
Article | Year |
---|---|
Tetramethylpyrazine Prevents Contrast-Induced Nephropathy via Modulating Tubular Cell Mitophagy and Suppressing Mitochondrial Fragmentation, CCL2/CCR2-Mediated Inflammation, and Intestinal Injury.
Topics: Animals; Glomerulonephritis, IGA; Inflammation Mediators; Intestines; Male; Mitochondria; Mitophagy; Pyrazines; Rats; Rats, Sprague-Dawley | 2019 |
Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.
Topics: Abatacept; Adult; Azathioprine; Biopsy; Boronic Acids; Bortezomib; Calcineurin Inhibitors; Cyclosporine; Glomerulonephritis, IGA; Graft Rejection; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisone; Pyrazines; Treatment Outcome | 2014 |